Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
DSI and HMSN
2 other identifiers
observational
563
2 countries
3
Brief Summary
The purpose of this research study is to create and validate two patient reported outcome (PRO) questionnaires. PRO questionnaires ask questions that help to measure disability in patients with inherited neuropathies. These questionnaires ask questions about what participants think disability is for themselves or others with inherited neuropathies. These questionnaires are a useful tool when evaluating whether treatments are working in the day to day life of an individual, although there are currently no questionnaires available specifically for people who have Charcot Marie Tooth disease (CMT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2014
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 2, 2014
CompletedFirst Posted
Study publicly available on registry
July 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedFebruary 7, 2019
February 1, 2019
4.8 years
April 2, 2014
February 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disability Severity Index
The DSI asks the subject to provide information about how disability is reflected in general by equipment required for mobility. Therefore, the DSI asks the subject if a person in general was wearing AFOs (braces) for mobility, what level of disability would that reflect using both a quantitative measurement of score and a verbal method of scoring (none, mild, moderate, severe). These questions do not apply to the participant themselves, just in general how disabled they believe a person to be based on the mobility assistive devices that that person requires. Then a research team member will complete the last page which specifically asks about what that subject is using for mobility.
Approximately 30 minutes
Secondary Outcomes (1)
Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
Approximately 30 minutes
Study Arms (2)
Participants evaluated at INC sites
Participants being evaluated at the INC sites will participate in both the DSI and HMSN-R-ODS by completing these PROs during their visit.
INC Contact Registry
INC Contact Registry completes the HMSN-R-ODS on web http://rarediseasesnetwork.epi.usf.edu/INC/
Eligibility Criteria
Participants enrolled in INC protocol 6601 and being seen at a participating site for an evaluation of CMT will be asked if they would like to participate in this protocol. The individuals being recruited will have already signed consent forms and be enrolled in 6601. They will be informed that it is completely voluntary to participate in this protocol, and they can still be enrolled in INC 6601 without participating in this project. Alternative participants who are registered with our INC Patient Registry will be alerted to the form through an email and asked to participate due to their diagnosis of suspected diagnosis of CMT.
You may qualify if:
- individual has an inherited peripheral neuropathy or is suspected to have an inherited peripheral neuropathy
- individual is 10-99 years of age
- individual signs consent or assent form depending on age and requirements
- individual is participating in INC 6601 at one of the participating sites OR is a participant on the INC Patient Registry
You may not qualify if:
- inability to provide informed consent
- outside of age range
- inability to complete questionnaire
- does not understand English
- is not participating in INC 6601 or on the INC Patient Registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Iowalead
- National Institute of Neurological Disorders and Stroke (NINDS)collaborator
- Charcot-Marie-Tooth Associationcollaborator
- Muscular Dystrophy Associationcollaborator
- University of Rochestercollaborator
- University of South Floridacollaborator
Study Sites (3)
University of Iowa
Iowa City, Iowa, 52242, United States
University of Rochester Medical Center
Rochester, New York, 14627, United States
National Hospital of Neurology and Neurosurgery
London, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael E Shy, MD
Universit of Iowa
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neurology
Study Record Dates
First Submitted
April 2, 2014
First Posted
July 18, 2014
Study Start
April 1, 2014
Primary Completion
February 1, 2019
Study Completion
February 1, 2019
Last Updated
February 7, 2019
Record last verified: 2019-02